Vanderbilt Memory and Alzheimer’s Center launches this year’s Tennessee Dementia ECHO program connecting health care professionals with dementia care experts

Since its launch in 2024, the program has expanded to serve clinicians across West, Middle and East Tennessee through regional partnerships with the University of Memphis and the University of Tennessee at Chattanooga.

Q+A: Angela Jefferson, PhD

Vanderbilt Health’s Mónica Santisteban to be honored by the American Heart Association

The recognition honors her research that has helped define how high blood pressure can contribute to cognitive impairment and Alzheimer’s disease.

Team’s AI agent to speed Alzheimer’s treatment

Patients who qualify for new Alzheimer’s disease therapies often wait weeks before receiving a first infusion.

Lower cardiac output predicts faster brain loss in carriers of Alzheimer’s disease risk gene

The study followed 756 participants over an 11-year period and examined whether reduced cardiac function could lead to adverse brain health outcomes even in the absence of cardiovascular disease.

Vanderbilt Center for Cognitive Medicine seeks participants for trial evaluating Alzheimer’s disease-related psychosis treatment

The ADEPT-4 study evaluates KarXT, an oral medication that may reduce hallucinations and delusions.